Boronic Acid RNA Tethering for Fragmented Analyte Preservation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for analyzing RNA in biological samples often result in the loss of nucleic acid analytes during sample preparation, particularly fragmented RNAs, due to issues like protein blocking and the need for large probe quantities, leading to gaps in understanding disease states.

Innovation Solution

The method involves anchoring or immobilizing ribonucleic acids, especially fragmented ones, using a boronic acid moiety that covalently reacts with 2′,3′ vicinal diols, forming a covalent bond with a matrix-forming agent to create a three-dimensional polymerized matrix, allowing for downstream analysis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If standard sample preparation protocols (permeabilization and de-crosslinking) are used to enable RNA analysis and imaging, then analysis capability is improved, but nucleic acid analytes are lost

Engineering Contradiction:
Improveanalysis capabilityVSAvoidnucleic acid analytes
Core Design Contradiction:
Ease of operationVSLoss of substance

Solution Approach 1:

The patent applies preliminary action by performing crosslinking of RNA to proteins or other molecules in the biological sample before sample preparation steps. This pre-crosslinking ensures that RNA analytes are anchored to the sample matrix, preventing their loss during subsequent permeabilization and de-crosslinking steps. The crosslinking is performed in situ, maintaining spatial orientation while securing the RNA for downstream analysis.

Inventive Principle:
Principle #10Preliminary action

2Loss of substance

If limited sample treatment is performed to preserve RNA intact, then RNA preservation is improved, but target analytes are blocked by proteins and ribosomes

Engineering Contradiction:
ImproveRNA preservationVSAvoidanalyte accessibility
Core Design Contradiction:
Loss of substanceVSDifficulty of detecting and measuring

Solution Approach 1:

The patent uses crosslinking reagents as intermediaries to bridge RNA analytes and the sample matrix (proteins, cellular structures). These crosslinkers form covalent bonds that attach RNA to surrounding molecules, making blocked analytes accessible for detection. The crosslinking creates a stable complex that allows subsequent probe hybridization and imaging without requiring extensive sample treatment that would compromise RNA integrity.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Measurement precision

If large quantities of probe materials are used to overcome blocking, then signal detection is improved, but cost and complexity increase

Engineering Contradiction:
Improvesignal detectionVSAvoidprobe quantity requirements
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

By performing crosslinking before probe hybridization, the patent ensures that RNA analytes are already secured to the sample matrix in their spatial context. This preliminary anchoring increases the efficiency of probe binding, as probes can hybridize to accessible crosslinked RNA without being lost during washing or processing steps. Consequently, lower probe quantities are required to achieve sufficient signal detection, reducing cost and simplifying the assay.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach effectively preserves and analyzes fragmented RNAs, reducing losses and enhancing the characterization of disease states by maintaining the spatial orientation of RNA molecules within the sample.

Implementation Method 1

contacting a biological sample comprising a ribonucleic acid (RNA) with an attachment agent comprising a boronic acid moiety capable of covalently reacting with at least one 2′,3′ vicinal diol of the RNA

Methodology Applied
Scientific EffectCovalent bonding: Chemical Bonding

Implementation Method 2

forming a three-dimensional polymerized matrix from the matrix-forming agent, thereby embedding the biological sample and immobilizing the RNA in the three-dimensional polymerized matrix

Methodology Applied
Scientific EffectPolymerization: Photopolymerisation

Data Source

PatentUS20240376521A1Boronic acid compositions and methods for tethering ribonucleic acids in biological samples
Publication Date: 2024.11.14 10X GENOMICS INC
  • US20240376521A1 patent drawing
  • US20240376521A1 patent drawing
  • US20240376521A1 patent drawing

AI summary

The present disclosure relates in some aspects to methods and boronic acid compositions for immobilizing RNA analytes in biological samples, and more specifically fragmented RNAs. RNA analytes may be tethered covalently or non-covalently to exogenous or endogenous molecules in a biological sample, for example, cross-linked directly to a polymerized three-dimensional matrix.